New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
08:48 EDTQGENQIAGEN price target raised to $26 from $20 at RW Baird
Baird raised its price target on QIAGEN following better than expected Q4 results. The firm cited higher guidance, tangible drivers of organic growth, and cash available for accretive use. Shares are Outperform rated.
News For QGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
16:14 EDTQGENQIAGEN sees Q1 adjusted EPS 22c-23c, consensus 25c
Subscribe for More Information
16:13 EDTQGENQIAGEN sees adjusted sales, EPS growing at constant exchange rates
Subscribe for More Information
16:11 EDTQGENQIAGEN reports Q4 adjusted EPS 25c, consensus 30c
Subscribe for More Information
15:37 EDTQGENNotable companies reporting after market close
Subscribe for More Information
08:13 EDTQGENQIAGEN management to meet with Evercore ISI
Subscribe for More Information
January 27, 2015
16:06 EDTQGENQIAGEN launches monitor to track immune function in organ transplant patients
QIAGEN N.V. announced the commercial launch of QuantiFERON Monitor, a diagnostic for monitoring immune function. QIAGEN is launching QuantiFERON Monitor in Europe as a CE-marked in-vitro diagnostic. Primary applications include monitoring of immune function in solid organ transplant recipients. In North America and other markets, QFM is available for research use as an accurate marker of immune function in studies of immunosuppressive conditions, immune modulating therapies and recovery following transplantation.
15:04 EDTQGENQIAGEN management to meet with Leerink
Meeting to be held in New York on February 3 hosted by Leerink.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use